Clinical impact of antimicrobial resistance: design matters.

[1]  A. Raglio,et al.  Clinical Impact of Antimicrobial Resistance in European Hospitals: Excess Mortality and Length of Hospital Stay Related to Methicillin-Resistant Staphylococcus aureus Bloodstream Infections , 2011, Antimicrobial Agents and Chemotherapy.

[2]  Peter Davey,et al.  Mortality associated with in-hospital bacteraemia caused by Staphylococcus aureus: a multistate analysis with follow-up beyond hospital discharge. , 2011, The Journal of antimicrobial chemotherapy.

[3]  M. D. Kraker,et al.  Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins. , 2011, The Journal of antimicrobial chemotherapy.

[4]  Gail M Williams,et al.  Schistosomiasis elimination: lessons from the past guide the future. , 2010, The Lancet. Infectious diseases.

[5]  T E Carpenter,et al.  Location of active transmission sites of Schistosoma japonicum in lake and marshland regions in China , 2009, Parasitology.

[6]  H. Lynn,et al.  Generalized negative binomial distribution: a promising statistical distribution for Oncomelania hupensis in the lake- and marsh-land regions of China , 2008, Annals of tropical medicine and parasitology.

[7]  Wu Xiaohua,et al.  Schistosomiasis control in China: the impact of a 10-year World Bank Loan Project (1992-2001). , 2005, Bulletin of the World Health Organization.

[8]  H. Tanaka,et al.  From discovery to eradication of schistosomiasis in Japan: 1847-1996. , 1997, International journal for parasitology.

[9]  K. Mertens,et al.  Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. , 2011, The Lancet. Infectious diseases.